← Leaderboards
Helena Yu
Sloan-Kettering Inst Can Research
$994,000
Attributed
$1,988,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $404.9K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,988,000 · 1
By mechanism
R01$1,988,000 · 1
Top collaborators
- Charles M Rudin5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Milind Rajadhyaksha$15,078,152
- Charles L Sawyers$34,701,646
- Yu Chen$11,691,795
- Amita Dave$3,998,296
- Craig B Thompson$56,520,903
Others in their field
Other Emerging Leaders on “Exome Sequencing”
- Leonard Freedman · Leidos Biomedical Research, Inc.$51,119,602
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,339,595
- Kim Doheny · Johns Hopkins University$20,098,530
- Badri N Vardarajan · University Of Miami School Of Medicine$19,910,969
- Brian William Kunkle · University Of Miami School Of Medicine$11,062,196
- Pradeep Natarajan · Massachusetts General Hospital$9,732,085
Research focus
Exome SequencingEzh2 GeneAdenocarcinomaCancer CellCancer TherapyBiological ModelsBisulfite SequencingCell LineCell LineageCellsCell TransformationCell TypeChemotherapyClinical TrialsCohortDisease ProgressionDrug ResistanceEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEpigenetic ProcessEpigenomicsEpithelial CellsEvolutionFrequencies
Grant awards (5)
Drivers of histologic transformation in EGFR-mutant lung cancer$404,888
R01 · FY2025 · CA · contact PI
Drivers of histologic transformation in EGFR-mutant lung cancer$384,644
R01 · FY2024 · CA · contact PI
Drivers of histologic transformation in EGFR-mutant lung cancer$396,790
R01 · FY2023 · CA · contact PI
Drivers of histologic transformation in EGFR-mutant lung cancer$396,790
R01 · FY2022 · CA · contact PI
Drivers of histologic transformation in EGFR-mutant lung cancer$404,888
R01 · FY2021 · CA · contact PI